Skip to content
Clinical Trials – home

LENOMORELIN (Ghrelin): A Comprehensive Guide for Patients

1 / 2
trials open to patients / all trials
2+
Countries

In short

Lenomorelin, also known as ghrelin, is a hormone primarily produced in the stomach that plays a crucial role in regulating appetite and energy balance. Recent clinical trials have been exploring its potential therapeutic applications in various medical conditions, including cancer-related weight loss, stroke recovery, alcohol dependence, and frailty in aging. This article summarizes the key findings from these trials and discusses the potential benefits and risks of using lenomorelin in medical treatments.

What is LENOMORELIN (Ghrelin)?

LENOMORELIN, also known as Ghrelin, is a naturally occurring hormone primarily produced by the stomach. It is often referred to as the "hunger hormone" because it plays a crucial role in regulating appetite and food intake. Ghrelin was first discovered in 1999 and has since been the subject of extensive research due to its potential therapeutic applications.

Other names for this hormone include:

  • Acylated Ghrelin
  • Octanoyl Ghrelin
  • Human acetylated ghrelin

How LENOMORELIN Works

LENOMORELIN works by binding to specific receptors in the body, primarily in the brain and stomach. Its main functions include:

  • Stimulating appetite: Ghrelin acts on the brain's hunger centers, increasing the desire to eat.
  • Promoting positive energy balance: It helps trigger a state where the body takes in more energy than it expends.
  • Stimulating growth hormone secretion: Ghrelin can increase the release of growth hormone from the pituitary gland.
  • Potential anti-inflammatory effects: Some research suggests ghrelin may have anti-inflammatory properties.

Potential Medical Uses

While LENOMORELIN is still primarily used in research settings, scientists are exploring its potential in treating various conditions:

  • Cancer-related cachexia: This is a condition of severe malnutrition and muscle wasting in advanced cancer patients. Ghrelin may help stimulate appetite and promote weight gain in these individuals.
  • Frailty in older adults: Researchers are investigating whether ghrelin can help improve food intake and physical function in frail elderly individuals.
  • Peripheral Artery Disease (PAD): Studies are exploring ghrelin's potential to improve functioning in people with PAD, a condition that affects blood flow to the limbs.
  • Stroke recovery: Some research is looking into whether ghrelin could improve recovery and long-term outcomes in patients who have had a stroke.
  • Alcohol dependence: Interestingly, researchers are studying how ghrelin might affect alcohol cravings and could potentially be used in treating alcohol dependence.

How LENOMORELIN is Administered

In clinical trials, LENOMORELIN is typically administered in one of the following ways:

  • Subcutaneous injection: This involves injecting the medication just under the skin.
  • Intravenous injection: The medication is injected directly into a vein.

The dosage and frequency of administration can vary widely depending on the specific study and condition being treated. It's important to note that outside of clinical trials, ghrelin is not currently approved for general medical use.

Ongoing Research and Clinical Trials

Several clinical trials are currently underway to better understand the potential benefits and risks of LENOMORELIN:

  • A study investigating ghrelin's effects on decision-making related to food choices and financial decisions.
  • Research on ghrelin's potential to improve appetite and nutritional status in cancer patients experiencing weight loss.
  • A trial exploring whether ghrelin can enhance recovery in stroke patients.
  • Studies on the use of ghrelin in frail elderly individuals to improve food intake and physical function.

Potential Side Effects and Safety

As LENOMORELIN is still primarily used in research settings, its full side effect profile is not yet fully understood. However, some potential effects observed in clinical trials include:

  • Changes in blood sugar levels: Ghrelin may affect glucose metabolism.
  • Changes in blood pressure: Some studies monitor blood pressure closely after ghrelin administration.
  • Effects on the cardiovascular system: Ghrelin may influence heart rate and blood flow.

It's crucial to note that the safety and efficacy of LENOMORELIN are still being studied, and it should only be used under close medical supervision in the context of approved clinical trials.

Questions people often ask

Conditions where Lenomorelin is being studied

Each condition opens its own overview and trial list

Trials with Lenomorelin

Recruiting trials first

See all 2 →
Quick filters
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).